Results from phase 3 study of (89)Zr-DFO-girentuximab for PET/CT imaging of clear cell renal cell carcinoma (ZIRCON) Meeting Abstract
| Authors: | Shuch, B. M.; Pantuck, A. J.; Bernhard, J. C.; Morris, M. A.; Master, V. A.; Scott, A. M.; Van Praet, C.; Bailly, C.; Aksoy, T.; Merkx, R.; Schuster, D. M.; Lee, S. T.; Pandit-Taskar, N.; Fan, A. C.; Tauchmanova, L.; Allman, P.; Vadali, K.; Hayward, C.; Mulders, P. |
| Abstract Title: | Results from phase 3 study of (89)Zr-DFO-girentuximab for PET/CT imaging of clear cell renal cell carcinoma (ZIRCON) |
| Meeting Title: | 2023 ASCO Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 41 |
| Issue: | 6 Suppl. |
| Meeting Dates: | 2023 Feb 16-18 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2023-02-20 |
| Language: | English |
| DOI: | 10.1200/JCO.2023.41.6_suppl.LBA602 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl |
| DOI/URL: | |
| Notes: | Meeting Abstract: LBA602 -- Source: Cinahl |
